GlassScriptPhysician profile
Lifei Guo
NPI 1275573297
$5,913.62
in general payments reported to CMS, 2019-2025
12 companies · $648 in 2025
The $648 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $497 · 2023: $2,366 · 2024: $2,402 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,041 · Honoraria: $1,100 · Travel and Lodging: $810 · Consulting Fee: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,041.02 |
| Honoraria | $1,100.00 |
| Travel and Lodging | $810.27 |
| Consulting Fee | $465.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,565.00 | 2023-2024 | |
| Axogen | $1,495.64 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Mentor Worldwide LLC | $1,148.74 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $448.89 | 2023-2024 | |
| Innovation Technologies INC | $281.93 | 2023 | Irrisept |
| Allergan, INC. | $211.94 | 2022 | |
| Smith+Nephew, INC. | $156.20 | 2023 | Renasys Go V2 Home, Pico, Renasys Touch |
| Baxter Healthcare | $146.67 | 2023 | |
| Sientra, INC. | $140.19 | 2022 | |
| Depuy Synthes Sales INC. | $138.18 | 2025 | Matrixwave, Matrixmandible |
| Organogenesis INC. | $124.99 | 2023 | Puraply Antimicrobial |
| Acera Surgical, INC. | $55.25 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lifei Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.